Bumitama Agri (SGX:P8Z)'s 4Q19 profits missed our and market estimates on lower-than-expected output and CPO ASP, and one-off expenses. We cut our FY20-21 EPS to factor in higher costs.
Bumitama Agri remains a BUY with Target Price SGD0.78 for its medium-term prospect and decent dividend yields of ~3-5%.
4Q Hurt by Lumpy Expenses and Low CPO ASP
4Q19 reported PATMI of IDR262b (+26% y-o-y, +38% q-o-q) would have been higher had it not been for the IDR29b one-off expenses related to the sales of its 28%-associate investment, and a IDR40b withholding tax on dividend income from its subsidiary.
Stripping off FX gains and Fair Value gain on biological assets, 4Q19 core PATMI was IDR185b (-19% y-o-y, -9% q-o-q), bringing 2019 core PATMI to IDR552b (-53% y-o-y), which met just 69%/56% of ours/consensus estimates.
Operationally, the relatively weak 4Q19 earnings were due to lower-than-expected CPO ASP of IDR7,156/kg (+18% y-o-y, +11% q-o-q), low PK ASP of IDR3,243/kg (-26% y-o-y. +6% q-o-q), and weaker-than-expected FFB output growth (+4% y-o-y, -8% q-o-q).
Up to 10% FFB Growth for FY20
For FY19, we estimate Bumitama Agri’s all-in operating cost of production at Rp4.53m/t (+35% y-o-y) or MYR1,328/t. Besides rising wages and fertilizer costs, the sharp increase in cost (per tonne) was also due to
lower-than-expected CPO yield (-4% y-o-y), hurt by the dry weather in 3Q19, and
low PK prices (-35% y-o-y).
There were also increased logistics costs as Bumitama Agri is increasingly selling more on CIF basis. As trees have unexpectedly rested in FY19 (-2% y-o-y in FFB output), Bumitama Agri is guiding for up to 10% FFB output growth in FY20 given its relatively young trees of 10.6yrs old, and cash cost per tonne to go up between 0-5% y-o-y.
Re-adjusting Our Assumptions
Following the higher-than-expected costs in FY19, we revised up our cost assumptions, trimmed our FY20 output by 2% (implying a 10% y-o-y growth), and lowered our FY20-21 EPS by 18%/9% respectively.
We take the opportunity to introduce our FY22 EPS.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....